| Net Cash Provided by (Used in) Operating Activities |
$8,990 |
USD |
0.44% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$8,990 |
USD |
-0.44% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
300,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
22,996,680 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
|
Q3 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$478,123 |
USD |
3.4% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$478,123 |
USD |
3.4% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,276,775 |
USD |
3.4% |
Q1 2025 |
FY 2025 |
| Additional Paid in Capital |
$141,469,948 |
USD |
0% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q1 2025 |
FY 2025 |
| Interest Expense |
$49,910 |
USD |
-0.27% |
Q3 2025 |
Q2 2026 |